NLRP3 and early-onset autosomal dominant Alzheimer disease: TXNIP up-regulation sustains neurodegeneration by activating NLRP3 inflammasome, and enhancing the expression of caspase-1 and IL-1β in the brains of Alzheimer's disease patients (Li 2019).